4BUL
Novel hydroxyl tricyclics (e.g. GSK966587) as potent inhibitors of bacterial type IIA topoisomerases
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID23-1 |
Synchrotron site | ESRF |
Beamline | ID23-1 |
Temperature [K] | 100 |
Detector technology | CCD |
Detector | ADSC QUANTUM 315 |
Spacegroup name | P 61 |
Unit cell lengths | 93.871, 93.871, 416.439 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 24.790 - 2.600 |
R-factor | 0.14494 |
Rwork | 0.144 |
R-free | 0.18277 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2xcs |
RMSD bond length | 0.007 |
RMSD bond angle | 1.178 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | REFMAC |
Refinement software | REFMAC (5.7.0032) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 81.380 | 2.740 |
High resolution limit [Å] | 2.600 | 2.600 |
Rmerge | 0.090 | 0.380 |
Number of reflections | 60721 | |
<I/σ(I)> | 9.5 | 2.3 |
Completeness [%] | 95.8 | 96.7 |
Redundancy | 2.4 | 2.4 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 |